Glycation in Huntington’s Disease: A Possible Modifier and Target for Intervention-Reference-Cited by-同舟云学术

Glycation in Huntington’s Disease: A Possible Modifier and Target for Intervention

Published:2019-08-27 Issue:3 Volume:8 Page:245-256
ISSN:1879-6397
Container-title:Journal of Huntington's Disease
language:
Short-container-title:JHD

Author:

Brás Inês Caldeira¹,König Annekatrin¹,Outeiro Tiago Fleming¹²³

Affiliation:

1. Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Göttingen, Göttingen, Germany

2. Max Planck Institute for Experimental Medicine, Göttingen, Germany

3. Institute of Neuroscience, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Clinical Neurology

Reference177 articles.

1. The role of advanced glycation end products in aging and metabolic diseases: Bridging association and causality;Chaudhuri;Cell Metab,2018

2. Advanced glycation end products and diabetic complications;Singh;Korean J Physiol Pharmacol,2014

3. Neurodegenerative disorders associated with diabetes mellitus;Ristow;J Mol Med,2004

4. Diabetes mellitus in Huntington disease;Farrer;Clin Genet,1985

5. Increased frequency of diabetes mellitus in patients with Huntington’s chorea;Podolsky;Lancet,1972

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenfuro®-mediated arrest in the formation of protein-methyl glyoxal adducts: a new dimension in the anti-hyperglycemic potential of a novel fenugreek seed extract;Toxicology Mechanisms and Methods;2024-06-04

2. Advanced Glycation End Products and Health: A Systematic Review;Annals of Biomedical Engineering;2024-05-05

3. Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review;International Journal of Biological Macromolecules;2024-04

4. An exploratory metabolomic comparison of participants with fast or absent functional progression from 2CARE, a randomized, double-blind clinical trial in Huntington’s disease;Scientific Reports;2024-01-11

5. Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes;Biomedicines;2023-11-07